{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T05:52:10Z","timestamp":1771307530547,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Physiology & Neurobiology"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.resp.2013.02.004","type":"journal-article","created":{"date-parts":[[2013,2,13]],"date-time":"2013-02-13T03:45:56Z","timestamp":1360727156000},"page":"11-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Immunological aspects of phosphodiesterase inhibition in the respiratory system"],"prefix":"10.1016","volume":"187","author":[{"given":"Juraj","family":"Mokry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Mokra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resp.2013.02.004_bib0005","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1513\/pats.200504-024SR","article-title":"Theophylline in chronic obstructive pulmonary disease. New horizons","volume":"2","author":"Barnes","year":"2005","journal-title":"Proceedings of American Thoracic Society"},{"key":"10.1016\/j.resp.2013.02.004_bib0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1378\/chest.129.1.151","article-title":"Reduced histone deacetylase in COPD: clinical implications","volume":"129","author":"Barnes","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.resp.2013.02.004_bib0015","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1513\/pats.200807-069TH","article-title":"Future treatments for chronic obstructive pulmonary disease and its comorbities","volume":"5","author":"Barnes","year":"2008","journal-title":"Proceedings of American Thoracic Society"},{"key":"10.1016\/j.resp.2013.02.004_bib0020","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1124\/pr.58.3.5","article-title":"Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use","volume":"58","author":"Bender","year":"2006","journal-title":"Pharmacological Reviews"},{"key":"10.1016\/j.resp.2013.02.004_bib0025","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.biopsych.2005.04.030","article-title":"A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder: a proof of concept study","volume":"58","author":"Brown","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.resp.2013.02.004_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2478\/v10201-011-0023-7","article-title":"Selective inhibition of phosphodiesterase 7 (PDE7) by BRL50481 in healthy and ovalbumin-sensitized guinea pigs","volume":"12","author":"Christensen","year":"2012","journal-title":"Acta Medica Martiniana"},{"key":"10.1016\/j.resp.2013.02.004_bib0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Chung","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0040","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2125.2008.03155.x","article-title":"Phosphodiesterase 4 inhibitors in chronic obstructive pulmonary disease: a new approach to oral treatment","volume":"65","author":"Currie","year":"2008","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0045","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1183\/09031936.00071307","article-title":"Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury","volume":"31","author":"De Visser","year":"2008","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.resp.2013.02.004_bib0050","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S1807-59322008000300006","article-title":"Insights into the regulation of TNF-\u03b1 production in human mononuclear cells: the effects of non-specific phosphodiesterase inhibition","volume":"63","author":"Deree","year":"2008","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.resp.2013.02.004_bib0055","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.rmed.2006.12.004","article-title":"Summing up 100 years of asthma","volume":"101","author":"Diamant","year":"2007","journal-title":"Respiratory Medicine"},{"key":"10.1016\/j.resp.2013.02.004_bib0060","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phrs.2003.03.001","article-title":"Aminophylline therapy during endotoxemia in anesthetized spontaneously breathing rats","volume":"49","author":"Fakioglu","year":"2004","journal-title":"Pharmaceutical Research"},{"key":"10.1016\/j.resp.2013.02.004_bib0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1465-9921-10-39","article-title":"A multi-target antisense approach against PDE4 and PDE7 reduces smoke-induced lung inflammation in mice","volume":"10","author":"Fortin","year":"2009","journal-title":"Respiratory Research"},{"key":"10.1016\/j.resp.2013.02.004_bib0070","series-title":"Handbook of Experimental Pharmacology 204","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-17969-3","article-title":"Phosphodiesterases as drug targets","author":"Francis","year":"2011"},{"key":"10.1016\/j.resp.2013.02.004_bib0075","series-title":"Handbook of Experimental Pharmacology 200","article-title":"Methyxanthines","year":"2011"},{"key":"10.1016\/j.resp.2013.02.004_bib0080","first-page":"1148","article-title":"Phosphodiesterase inhibitors: their role and implications","volume":"1","author":"Ghosh","year":"2009","journal-title":"International Journal PharmTech Research"},{"key":"10.1016\/j.resp.2013.02.004_bib0085","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1111\/j.1476-5381.1996.tb15629.x","article-title":"Identification of cyclic AMP phosphodiesterases 3, 4 and 7 in human CD4+ and CD8+ T-lymphocytes: role in regulating proliferation and the biosynthesis of interleukin-2","volume":"118","author":"Giembycz","year":"1996","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0090","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coph.2005.04.001","article-title":"Life after PDE4: overcoming adverse events with dual-specificity phosphodiesterase inhibitors","volume":"5","author":"Giembycz","year":"2005","journal-title":"Current Opinion in Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0095","unstructured":"Global strategy for the diagnosis and management of asthma in children 5 years and younger [online]. 2011 [cited 2012 11 24]. Available from: http:\/\/www.ginasthma.org."},{"key":"10.1016\/j.resp.2013.02.004_bib0100","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1378\/chest.07-0829","article-title":"Targeting airway inflammation in asthma\u2013current and future therapies","volume":"133","author":"Hanania","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.resp.2013.02.004_bib0105","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1358\/dot.2004.40.1.799438","article-title":"Theophylline: mechanism of action and use in asthma and chronic obstructive pulmonary disease","volume":"40","author":"Hansel","year":"2004","journal-title":"Drugs Today"},{"key":"10.1016\/j.resp.2013.02.004_bib0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MCP.0b013e32831da867","article-title":"Novel targets of therapy in asthma","volume":"15","author":"Holgate","year":"2009","journal-title":"Current Opinion in Pulmonary Medicine"},{"key":"10.1016\/j.resp.2013.02.004_bib0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj20021698","article-title":"PDE4 cAMP phosphodiesterase: modular enzymes that orchestrate signalling cross-talk, desensitization and compartmentalization","volume":"370","author":"Houslay","year":"2003","journal-title":"Biochemical Journal"},{"key":"10.1016\/j.resp.2013.02.004_bib0120","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s00210-001-0494-x","article-title":"Theophylline inhibits NF-\u03baB activation and I\u03baB\u03b1 degradation in human pulmonary epithelial cells","volume":"364","author":"Ischiyama","year":"2001","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0125","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ijcard.2004.09.002","article-title":"Safety and efficacy of sildenafil therapy in children with pulmonary hypertension","volume":"100","author":"Karatza","year":"2005","journal-title":"International Journal of Cardiology"},{"key":"10.1016\/j.resp.2013.02.004_bib0130","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.pupt.2007.01.007","article-title":"Pretreatment with olprinone hydrochloride, a phosphodiesterase III inhibitor, attenuates lipopolysaccharide-induced lung injury via and anti-inflammatory effect","volume":"21","author":"Koike","year":"2008","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1016\/j.resp.2013.02.004_bib0135","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1203\/01.PDR.0000145256.19073.E4","article-title":"Pentoxyfylline reduces regional inflammatory and ventilatory disturbances in meconium-exposed piglet lungs","volume":"56","author":"Korhonen","year":"2004","journal-title":"Pediatric Research"},{"key":"10.1016\/j.resp.2013.02.004_bib0140","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1111\/j.1365-2362.1995.tb01731.x","article-title":"Aminophylline: could it act as an antioxidant in vivo?","volume":"25","author":"Lapenna","year":"1995","journal-title":"European Journal of Clinical Investigation"},{"key":"10.1016\/j.resp.2013.02.004_bib0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ejcts.2004.02.024","article-title":"Effects of aminophylline on cytokines and pulmonary functions undergoing valve replacement","volume":"25","author":"Luo","year":"2004","journal-title":"European Journal of Cardio-Thoracic Surgery"},{"key":"10.1016\/j.resp.2013.02.004_bib0150","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S1081-1206(10)63476-X","article-title":"Anti-inflammatory effects of theophylline: modulation of cytokine production","volume":"77","author":"Mascali","year":"1996","journal-title":"Annals of Allergy, Asthma, and Immunology"},{"key":"10.1016\/j.resp.2013.02.004_bib0155","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.tips.2011.04.003","article-title":"Novel bronchodilators for the treatment of chronic obstructive pulmonary disease","volume":"32","author":"Matera","year":"2011","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.resp.2013.02.004_bib0160","series-title":"Meconium Aspiration Syndrome: From Pathomechanisms to Treatment","author":"Mokra","year":"2010"},{"key":"10.1016\/j.resp.2013.02.004_bib0165","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pupt.2012.02.007","article-title":"Selective phosphodiesterase 3 inhibitor olprinone attenuates meconium-induced oxidative lung injury","volume":"25","author":"Mokra","year":"2012","journal-title":"Pulmonary Pharmacology and Therapeutics"},{"key":"10.1016\/j.resp.2013.02.004_bib0170","first-page":"399","article-title":"Aminophylline treatment in meconium-induced acute lung injury in a rabbit model","volume":"58","author":"Mokra","year":"2007","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0175","first-page":"473","article-title":"Influence of selective inhibitors of phosphodiesterase 3 and 4 on cough and airway reactivity","volume":"59","author":"Mokry","year":"2008","journal-title":"Journal of Physiology and Pharmacology"},{"issue":"3","key":"10.1016\/j.resp.2013.02.004_bib0180","first-page":"131","article-title":"The influence of the PDE inhibitors on cough reflex in guinea pigs","volume":"112","author":"Mokry","year":"2011","journal-title":"Bratislavske Lekarske Listy"},{"key":"10.1016\/j.resp.2013.02.004_bib0185","first-page":"87","article-title":"Influence of xanthine derivatives on cough and airway reactivity in guinea pigs","volume":"60","author":"Mokry","year":"2009","journal-title":"Journal of Physiology and Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0190","first-page":"51","article-title":"New opinions on the mechanism of action of xanthine derivatives","volume":"10","author":"Nosalova","year":"2000","journal-title":"Slovakofarma"},{"key":"10.1016\/j.resp.2013.02.004_bib0195","first-page":"14","article-title":"The mechanism of action of xanthine derivatives and suppression of cough","volume":"1","author":"Nosalova","year":"2001","journal-title":"Acta Medica Martiniana"},{"key":"10.1016\/j.resp.2013.02.004_bib0200","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1440-1681.1978.tb00707.x","article-title":"Inhibition of human pulmonary phosphodiesterase activity by therapeutic levels of theophylline","volume":"5","author":"Polson","year":"1978","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.resp.2013.02.004_bib0205","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1183\/09031936.95.08040637","article-title":"Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants","volume":"8","author":"Rabe","year":"1995","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.resp.2013.02.004_bib0210","first-page":"3","volume":"68","author":"Rennard","year":"2008","journal-title":"The efficacy and safety of cilomilast in COPD"},{"key":"10.1016\/j.resp.2013.02.004_bib0215","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.pharmthera.2004.12.001","article-title":"PDE4 inhibitors as new antiinflammatory drugs: effects on cell trafficking and cell adhesion molecules expression","volume":"106","author":"Sanz","year":"2005","journal-title":"Pharmacology and Therapeutics"},{"key":"10.1016\/j.resp.2013.02.004_bib0220","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1161\/01.CIR.0000074226.20466.B1","article-title":"Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension","volume":"107","author":"Sebkhi","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.resp.2013.02.004_bib0225","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0079-6603(00)66031-2","article-title":"Regulation and function of the cyclic nucleotide phosphodiesterase (PDE3) gene family","volume":"66","author":"Shakur","year":"2001","journal-title":"Progress in Nucleic Acid Research and Molecular Biology"},{"key":"10.1016\/j.resp.2013.02.004_bib0230","doi-asserted-by":"crossref","first-page":"L279","DOI":"10.1152\/ajplung.00170.2002","article-title":"Ubiquitous expression of phosphodiesterase 7A in human proinflammatory and immune cells","volume":"284","author":"Smith","year":"2003","journal-title":"American Journal of Physiology \u2013 Lung Cellular and Molecular Physiology"},{"key":"10.1016\/j.resp.2013.02.004_bib0235","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejphar.2005.12.056","article-title":"Adenosine in the airways: implications and applications","volume":"533","author":"Spicuzza","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0240","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/bjp.2008.307","article-title":"PDE4 inhibitors: current sttus","volume":"155","author":"Spina","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0245","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1055\/s-2002-35367","article-title":"Inhibition of meconium induced activation of granulocytes from neonates and adults by pentoxyphylline","volume":"214","author":"Tegtmeyer","year":"2002","journal-title":"Klinische Padiatrie"},{"key":"10.1016\/j.resp.2013.02.004_bib0250","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1164\/rccm.200211-1372OC","article-title":"Effect of phosphodiesterase-5 inhibitor, sildenafil (Viagra), in animal models of irways disease","volume":"169","author":"Toward","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.resp.2013.02.004_bib0255","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1183\/09031936.00068908","article-title":"A controlled trial of 6-weeks treatment with a novel inhaled phosphodiesterase type-4 inhibitor in COPD","volume":"33","author":"Vestbo","year":"2009","journal-title":"European Respiratory Journal"},{"key":"10.1016\/j.resp.2013.02.004_bib0260","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.intimp.2009.11.008","article-title":"Zl-n-91, a selective phosphodiesterase 4 inhibitor, supresses inflammatory response in a COPD-like rat model","volume":"10","author":"Wang","year":"2010","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1164\/rccm.200411-1587OC","article-title":"Antiproliferative effects of phosphodiesterase type 5 inhibition in human pulmonary artery cells","volume":"172","author":"Wharton","year":"2005","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1016\/j.resp.2013.02.004_bib0270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejphar.2006.08.023","article-title":"Pharmacological profile of a novel phosphodiesterase 7A and -4 dual inhibitor, YM-393059, on acute and chronic inflammation models","volume":"550","author":"Yamamoto","year":"2006","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.resp.2013.02.004_bib0275","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1164\/ajrccm\/142.5.1073","article-title":"Attenuation of tumor necrosis factor-induced endothelial cell cytotoxicity and neutrophil chemiluminescence","volume":"142","author":"Zheng","year":"1990","journal-title":"American Review of Respiratory Disease"}],"container-title":["Respiratory Physiology & Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904813000347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904813000347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:29:10Z","timestamp":1761604150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569904813000347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S1569904813000347"],"URL":"https:\/\/doi.org\/10.1016\/j.resp.2013.02.004","relation":{},"ISSN":["1569-9048"],"issn-type":[{"value":"1569-9048","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunological aspects of phosphodiesterase inhibition in the respiratory system","name":"articletitle","label":"Article Title"},{"value":"Respiratory Physiology & Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resp.2013.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}